Kalandavis LLC

PRO Pharmaceuticals, based in Newton Center, MA, specializes in innovative cancer therapies, particularly through its carbohydrate-based drug enhancement formulation known as DAVANAT. The company is actively engaged in clinical trials for cancer treatment, including Phase I studies at notable cancer centers such as the Norris Cotton Cancer Center and Ochsner Cancer Institute. With a focus on advancing research, PRO Pharmaceuticals has appointed experts to its Scientific Advisory Board and has received patent allowances for its carbohydrate linker technology. The organization is committed to enhancing existing cancer drugs, reflected in its ongoing multi-center clinical trials targeting various solid tumors. Generated from the website

Pro-Pharmaceuticals is a biotechnology company based in Newton Center, MA, focused on developing innovative cancer treatments utilizing carbohydrate linker technology. The company is actively engaged in clinical trials and collaborations with notable institutions to advance its lead product, DAVANAT, in the fight against various solid tumors. Since its inception, Pro-Pharmaceuticals has made significant strides, including receiving FDA approval for clinical trials and publishing research in peer-reviewed journals. With a dedicated scientific advisory board and a commitment to enhancing existing cancer therapies, the company aims to improve patient outcomes through its cutting-edge research and development efforts. Generated from the website